Inventor · disambiguated record
Mathieu Charveriat
Also filed as: CHARVERIAT MATHIEU
3 granted patents·4 pending applications·11 citations·filing 2009–2021
61Inventor score
Top patents by PatentIndex Score
7 records- 0183US9750734B2Use of flecainide as an anti-connexin agent and method for potentiating the effects of a psychotropic drugCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2014·Granted Sep 5, 2017·10 cites·22 claims
- 0270US11077080B2Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugsCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2015·Granted Aug 3, 2021·1 cites·3 claims
- 0359US10765670B2Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitorsCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2018·Granted Sep 8, 2020·0 cites·7 claims
- 0455US2021308120A1Use of Amitriptyline for Blocking Brain Hemichannels and Method for Potentiating its Effect in VivoTHERANEXUS·Filed 2021·Application pending·0 cites
- 0554US2012135960A2Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugsMOUTHON FRANCK·Filed 2009·Application pending·0 cites
- 0651US2015011584A1Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitorsCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2012·Application pending·0 cites
- 0736US2018207147A1Use of amitriptyline for blocking brain hemichannels and method for potentiating its effect in vivoTHERANEXUS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mathieu Charveriat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →